Conyers provided Cayman Islands legal advice to Novena Global Healthcare Limited (the Company) in connection with its financing.
The Company arranged equity financing through the creation and issue of Series A preferred shares raising US$20 million in funding from Sinopharm Capital and Cedarlake Capital Group.
The Company is a healthcare platform focusing on aesthetic and healthcare businesses with over 100 clinics globally and was founded at Singapore. It offers unique DNA testing, health screening services and stem cell treatments.
Director Preetha Pillai of Conyers’ Singapore office and Associate Charissa Ball of Conyers’ Hong Kong office advised on the matter.